Azilsartan attenuates lipopolysaccharide-induced acute lung injury via the Nrf2/HO-1 signaling pathway

Azilsartan attenuates lipopolysaccharide-induced acute lung injury via the Nrf2/HO-1 signaling pathway

Acute lung harm (ALI) is a extreme complication of sepsis and hemorrhagic shock with excessive morbidity. Within the current research, the protecting impact of Azilsartan on lipopolysaccharide (LPS)-induced ALI in mice was investigated to discover the potential therapeutic property of Azilsartan for the therapy of ALI. LPS was used to induce an ALI mannequin in […]